Different Doses of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• المؤلفون الرئيسيون: Xin Wu (مؤلف), Tao Xue (مؤلف), Zilan Wang (مؤلف), Zhouqing Chen (مؤلف), Xuwei Zhang (مؤلف), Wei Zhang (مؤلف), Zhong Wang (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: The efficacy and safety of fingolimod for relapsing-remitting multiple sclerosis (RRMS) had been well verified in several large randomized controlled trials (RCTs) during the past decade. However, there are fewer systematic comparisons of different doses of fingolimod and whether the dos...